Literature DB >> 6258178

The role of central serotonergic mechanisms on head-twitch and backward locomotion induced by hallucinogenic drugs.

T Yamamoto, S Ueki.   

Abstract

Head-twitch induced by lysergic acid diethylamide, mescaline and 2,5-dimethoxy-4-methylamphetamine (DOM) was significantly increased by medial raphe (m-R) lesions, but dorsal raphe (d-R) lesions did not produce any changes. Hallucinogen-induced head twitch was inhibited by methysergide and tended to be increased by PCPA. These results suggest that 5-HT receptors innervated with the ascending 5-HT pathway originating in the m-R play a vital role in the manifestation of hallucinogen-induced head-twitch. That is, increase of head-twitch is ascribed to supersensitivity of 5-HT receptors. On the other hand, DOM-induced backward locomotion was inhibited by m-R or both dorsal and medial raphe lesions and methysergide, and was reversed to forward locomotion, differently from the hallucinogen-induced head-twitch. A reversion of backward locomotion was not obtained with d-R lesions or PCPA treatment.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6258178     DOI: 10.1016/0091-3057(81)90108-8

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  6 in total

1.  Central serotonin receptors: effector systems, physiological roles and regulation.

Authors:  P J Conn; E Sanders-Bush
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

2.  Enhanced head-twitch response to 5-HT-related agonists in thiamine-deficient mice.

Authors:  O Nakagawasai; A Murata; Y Arai; A Ohba; K Wakui; S Mitazaki; F Niijima; K Tan-No; T Tadano
Journal:  J Neural Transm (Vienna)       Date:  2007-03-20       Impact factor: 3.575

3.  Pharmacodynamic effects of serotonin (5-HT) receptor ligands in pigs: stimulation of 5-HT2 receptors induces malignant hyperthermia.

Authors:  W Löscher; U Witte; G Fredow; M Ganter; K Bickhardt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-06       Impact factor: 3.000

4.  Serotonergic and dopaminergic distinctions in the behavioral pharmacology of (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD).

Authors:  Emmanuelle A D Schindler; Kuldip D Dave; Elaine M Smolock; Vincent J Aloyo; John A Harvey
Journal:  Pharmacol Biochem Behav       Date:  2011-12-14       Impact factor: 3.533

Review 5.  Animal models of serotonergic psychedelics.

Authors:  James B Hanks; Javier González-Maeso
Journal:  ACS Chem Neurosci       Date:  2012-09-24       Impact factor: 4.418

Review 6.  Psychedelics.

Authors:  David E Nichols
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.